β-Cell adaptation in pregnancy

Diabetes, Obesity and Metabolism

Volumn 18, Issue , 2016, Pages 63-70

  Baeyens, L ^a   Hindi, S ^a,b   Sorenson, R L ^c   German, M S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

gestational diabetes; Htr1d; Htr2b; Htr3a; insulin; placenta; placental lactogen; pregnancy; serotonin; cell

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FOXD3 PROTEIN; FOXM1 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTA LACTOGEN; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN KINASE B; RAF PROTEIN; RAP PROTEIN; RAS PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SEROTONIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; GLUCOSE; INSULIN;

ADAPTATION; B LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; GENE DUPLICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; NONHUMAN; PREGNANCY; PREGNANCY DIABETES MELLITUS; PUERPERIUM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; FEMALE; INSULIN RESISTANCE; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; RAT; SECRETION (PROCESS);

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL PROLIFERATION; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; PLACENTAL LACTOGEN; POSTPARTUM PERIOD; PREGNANCY; RATS; SEROTONIN;

EID: 84987794556     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12716     Document Type: Review

References (86)

1. Hay WW Jr. Energy and substrate requirements of the placenta and fetus. Proc Nutr Soc. 1991;50:321–336.
2. Battaglia FC. Principal substrates of fetal metabolism: fuel and growth requirements of the ovine fetus. Ciba Found Symp. 1978;63:57–74.
3. Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 2002;19:13–22.
4. Asplund K, Westman S, Hellerstrom C. Glucose stimulation of insulin secretion from the isolated pancreas of foetal and newborn rats. Diabetologia. 1969;5:260–262.
5. Espinosa de los M, Driscoll SG, Steinke J. Insulin release from isolated human fetal pancreatic islets. Science. 1970;168:1111–1112.
6. Nolan CJ, Proietto J. The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia. 1994;37:976–984.
7. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50:938–948.
8. Hellman B. The islets of Langerhans in the rat during pregnancy and lactation, with special reference to the changes in the B/A cell ratio. Acta Obstet Gynecol Scand. 1960;39:331–342.
9. Green IC, Taylor KW. Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. J Endocrinol. 1972;54:317–325.
10. Van Assche FA. Quantitative morphologic and histoenzymatic study of the endocrine pancreas in nonpregnant and pregnant rats. Am J Obstet Gynecol. 1974;118:39–41.
11. Bone AJ, Taylor KW. Metabolic adaptation to pregnancy shown by increased biosynthesis of insulin in islets of Langerhans isolated from pregnant rat. Nature. 1976;262:501–502.
12. Van Assche FA, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol. 1978;85:818–820.
13. Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology. 1992;130:1459–1466.
14. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res. 1997;29:301–307.
15. Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science. 2007;318:806–809.
16. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia. 2010;53:2167–2176.
17. Rieck S, Kaestner KH. Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab. 2010;21:151–158.
18. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell. 2007;12:817–826.
19. Abouna S, Old RW, Pelengaris S, et al. Non-β-cell progenitors of β-cells in pregnant mice. Organogenesis. 2010;6:125–133.
20. Xiao X, Chen Z, Shiota C, et al. No evidence for beta cell neogenesis in murine adult pancreas. J Clin Invest. 2013;123:2207–2217.
21. Toselli C, Hyslop CM, Hughes M, Natale DR, Santamaria P, Huang CT. Contribution of a non-beta-cell source to beta-cell mass during pregnancy. PLoS One. 2014;9:e100398.
22. Marynissen G, Aerts L, Van Assche FA. The endocrine pancreas during pregnancy and lactation in the rat. J Dev Physiol. 1983;5:373–381.
23. Scaglia L, Smith FE, Bonner-Weir S. Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology. 1995;136:5461–5468.
24. Brelje TC, Allaire P, Hegre O, Sorenson RL. Effect of prolactin versus growth hormone on islet function and the importance of using homologous mammosomatotropic hormones. Endocrinology. 1989;125:2392–2399.
25. Brelje TC, Sorenson RL. Role of prolactin versus growth hormone on islet B-cell proliferation in vitro: implications for pregnancy. Endocrinology. 1991;128:45–57.
26. Brelje TC, Scharp DW, Lacy PE, et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology. 1993;132:879–887.
27. Freemark M, Avril I, Fleenor D, et al. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology. 2002;143:1378–1385.
28. Amaral ME, Cunha DA, Anhe GF, et al. Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy. J Endocrinol. 2004;183:469–476.
29. Huang C, Snider F, Cross JC. Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology. 2009;150:1618–1626.
30. Rawn SM, Huang C, Hughes M, Shaykhutdinov R, Vogel HJ, Cross JC. Pregnancy hyperglycemia in prolactin receptor mutant, but not prolactin mutant, mice and feeding-responsive regulation of placental lactogen genes implies placental control of maternal glucose homeostasis. Biol Reprod. 2015;93:75.
31. Goyvaerts L, Lemaire K, Arijs I, et al. Prolactin receptors and placental lactogen drive male mouse pancreatic islets to pregnancy-related mRNA changes. PLoS One. 2015;10:e0121868.
32. Moldrup A, Petersen ED, Nielsen JH. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology. 1993;133:1165–1172.
33. Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16:804–808.
34. Brooks CL. Molecular mechanisms of prolactin and its receptor. Endocr Rev. 2012;33:504–525.
35. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19:225–268.
36. Rieck S, White P, Schug J, et al. The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol. 2009;23:1702–1712.
37. Schraenen A, Lemaire K, de Faudeur G, et al. Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia. 2010;53:2589–2599.
38. Layden BT, Durai V, Newman MV, et al. Regulation of pancreatic islet gene expression in mouse islets by pregnancy. J Endocrinol. 2010;207:265–279.
39. Ohta Y, Kosaka Y, Kishimoto N, et al. Convergence of the insulin and serotonin programs in the pancreatic beta-cell. Diabetes. 2011;60:3208–3216.
40. Goyvaerts L, Schraenen A, Schuit F. Serotonin competence of mouse beta cells during pregnancy. Diabetologia. 2016;59:1356–1363.
41. Amireault P, Sibon D, Cote F. Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem Neurosci. 2013;4:64–71.
42. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Ann Rev Med. 2009;60:355–366.
43. Zawalich WS, Tesz GJ, Zawalich KC. Are 5-hydroxytryptamine-preloaded beta-cells an appropriate physiologic model system for establishing that insulin stimulates insulin secretion? J Biol Chem. 2001;276:37120–37123.
44. Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157–203.
45. Gylfe E. Association between 5-hydroxytryptamine release and insulin secretion. J Endocrinol. 1978;78:239–248.
46. Smith PA, Proks P, Ashcroft FM. Quantal analysis of 5-hydroxytryptamine release from mouse pancreatic beta-cells. J Physiol. 1999;521(Pt 3):651–664.
47. Dadon D, Tornovsky-Babaey S, Furth-Lavi J, et al. Glucose metabolism: key endogenous regulator of beta-cell replication and survival. Diabetes Obes Metab. 2012;14(Suppl 3):101–108.
48. Berger M, Scheel DW, Macias H, et al. Galphai/o-coupled receptor signaling restricts pancreatic beta-cell expansion. Proc Natl Acad Sci USA. 2015;112:2888–2893.
49. Guettier JM, Gautam D, Scarselli M, et al. A chemical-genetic approach to study G protein regulation of beta cell function in vivo. Proc Natl Acad Sci USA. 2009;106:19197–19202.
50. Amaral ME, Ueno M, Carvalheira JB, et al. Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway. Horm Metab Res. 2003;35:282–289.
51. Zahr E, Molano RD, Pileggi A, et al. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation. 2007;84:1576–1583.
52. Hughes E, Huang C. Participation of Akt, menin, and p21 in pregnancy-induced beta-cell proliferation. Endocrinology. 2011;152:847–855.
53. Chamberlain CE, Scheel DW, McGlynn K, et al. Menin determines K-RAS proliferative outputs in endocrine cells. J Clin Invest. 2014;124:4093–4101.
54. Hakonen E, Ustinov J, Mathijs I, et al. Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia. 2011;54:1735–1743.
55. Hakonen E, Ustinov J, Palgi J, Miettinen PJ, Otonkoski T. EGFR signaling promotes beta-cell proliferation and survivin expression during pregnancy. PLoS One. 2014;9:e93651.
56. Miettinen PJ, Ustinov J, Ormio P, et al. Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes. 2006;55:3299–3308.
57. Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO. Islet endothelial cells and pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology. 2006;147:2315–2324.
58. Demirci C, Ernst S, Alvarez-Perez JC, et al. Loss of HGF/c-Met signaling in pancreatic beta-cells leads to incomplete maternal beta-cell adaptation and gestational diabetes mellitus. Diabetes. 2012;61:1143–1152.
59. Filios SR, Shalev A. Beta-cell MicroRNAs: small but powerful. Diabetes. 2015;64:3631–3644.
60. Jacovetti C, Abderrahmani A, Parnaud G, et al. MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity. J Clin Invest. 2012;122:3541–3551.
61. Plank JL, Frist AY, LeGrone AW, Magnuson MA, Labosky PA. Loss of Foxd3 results in decreased beta-cell proliferation and glucose intolerance during pregnancy. Endocrinology. 2011;152:4589–4600.
62. Zhang H, Zhang J, Pope CF, et al. Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes. 2010;59:143–152.
63. Zhang H, Ackermann AM, Gusarova GA, et al. The FoxM1 transcription factor is required to maintain pancreatic beta-cell mass. Mol Endocrinol. 2006;20:1853–1866.
64. Gupta RK, Gao N, Gorski RK, et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev. 2007;21:756–769.
65. Gupta RK, Vatamaniuk MZ, Lee CS, et al. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. J Clin Invest. 2005;115:1006–1015.
66. Miura A, Yamagata K, Kakei M, et al. Hepatocyte nuclear factor-4α is essential for glucose-stimulated insulin secretion by pancreatic β-cells. J Biol Chem. 2006;281:5246–5257.
67. Sorenson RL, Brelje TC, Roth C. Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology. 1993;133:2227–2234.
68. Ohara-Imaizumi M, Kim H, Yoshida M, et al. Serotonin regulates glucose-stimulated insulin secretion from pancreatic beta cells during pregnancy. Proc Natl Acad Sci USA. 2013;110:19420–19425.
69. Weinhaus AJ, Stout LE, Sorenson RL. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets. Endocrinology. 1996;137:1640–1649.
70. Weinhaus AJ, Bhagroo NV, Brelje TC, Sorenson RL. Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy. Diabetes. 1998;47:1426–1435.
71. Sorenson RL, Brelje TC, Hegre OD, Marshall S, Anaya P, Sheridan JD. Prolactin (in vitro) decreases the glucose stimulation threshold, enhances insulin secretion, and increases dye coupling among islet B cells. Endocrinology. 1987;121:1447–1453.
72. Cunha DA, Amaral ME, Carvalho CP, Collares-Buzato CB, Carneiro EM, Boschero AC. Increased expression of SNARE proteins and synaptotagmin IV in islets from pregnant rats and in vitro prolactin-treated neonatal islets. Biol Res. 2006;39:555–566.
73. Chuong EB, Hannibal RL, Green SL, Baker JC. Evolutionary perspectives into placental biology and disease. Appl Transl Genom. 2013;2:64–69.
74. Haig D. Placental growth hormone-related proteins and prolactin-related proteins. Placenta. 2008;29(Suppl):36–41.
75. Dolensek J, Rupnik MS, Stozer A. Structural similarities and differences between the human and the mouse pancreas. Islets. 2015;7:e1024405.
76. Wang P, Fiaschi-Taesch NM, Vasavada RC, Scott DK, Garcia-Ocana A, Stewart AF. Diabetes mellitus – advances and challenges in human beta-cell proliferation. Nat Rev Endocrinol. 2015;11:201–212.
77. Parnaud G, Bosco D, Berney T, et al. Proliferation of sorted human and rat beta cells. Diabetologia. 2008;51:91–100.
78. Chen H, Kleinberger JW, Takane KK, et al. Augmented Stat5 signaling bypasses multiple impediments to lactogen-mediated proliferation in human beta-cells. Diabetes. 2015;64:3784–3797.
79. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(Suppl 1):S13–S22.
80. Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care. 2007;30(Suppl 2):S105–S111.
81. VanDorsten JP, Dodson WC, Espeland MA, et al. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013. Obstet Gynecol. 2013;122:358–369.
82. Group HSCR, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.
83. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–1348.
84. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868.
85. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–1779.
86. O'Sullivan JB. The Boston gestational diabetes studies: review and perspectives. In: Sutherland HW, Stowers JM, Pearson DWM, eds. Carbohydrate Metabolism in Pregnancy and the Newborn IV London, England: Springer; 1989:287–294.